BIOX Cash Flow Statement (2016-2022) | BIOX

Cash Flow Statement Dec2016 Jun2021 Dec2021 Jun2022
Operating Activities
Net Income (Quarter) -3.58M-3.04M-8.56M
Depreciation and Depletion (Quarter) 0.30M0.30M
Gains from Investment Securities (Quarter) 12.68M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.30M0.30M